Best of Dermatology Coverage in 2022

The ADORING 3 phase 3 development program is currently studying the novel, aryl hydrocarbon receptor agonist as a once-daily, cosmetically elegant, and steroid-free topical cream for adults and children with atopic dermatitis.

Abeona Therapeutics’ pz-cel is an investigational autologous, COL7A1 gene-corrected epidermal sheet therapy for the treatment of recessive dystrophic epidermolysis bullosa.

Christopher Bunick, MD, PhD, FAAD, an associate professor of dermatology and a physician-scientist at the Yale School of Medicine in New Haven, Connecticut, presented updates on benzene in BPO at the 2024 American Academy of Dermatology Annual Meeting.

The average US household spent $645 on OTC products in 2022.

A lack of diversity in clinical trials has hampered health care providers from understanding the nuances of diseases across specific patient populations.

Following investigation by the independent testing laboratory, Valisure found acne products that contain up to 12 times the allowed of benzene.